John Huemoeller, CEO of AXIM Biotechnologies, discusses his company’s recently announced COVID-19 test that aims to speed up the COVID testing process that would, hopefully, lead to a COVID-19 vaccine more quickly. Huemoeller chats about AXIM’s pivot into cancer care.
